Publications & News

Fed. Circ. Undoes Breckenridge Generic Laxative Patent Win

May 5, 2017

By Christopher R. Noyes

Law360 explores the Federal Circuit's ruling that Breckenridge Pharmaceutical Inc.'s planned generic version of the laxative drug Suprep infringes a patent owned by WilmerHale client Braintree Laboratories Inc., reversing a New York federal judge's 2016 ruling.